is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices.
Above text from Wikipedia is available under the CC-BY-SA license.
- 1. Wikipedia. Eisai (company)
- 2. Department for Business, Innovation and Skills. Ministerial meetings with outside interests, 1 Jan - 31 Mar 2011
This profile was compiled by Who's Lobbying and is about Eisai.
This page is not endorsed by or affiliated with Eisai.
Problem with this information?
Please let us know by emailing: